Ledipasvir/sofosbuvir

From WikiMD.org
Jump to navigation Jump to search

Ledipasvir/Sofosbuvir

Ledipasvir/Sofosbuvir (pronunciation: leh-dih-PASS-vir/soh-FOSS-buh-vir) is a fixed-dose combination medication used in the treatment of hepatitis C. It combines ledipasvir and sofosbuvir, two antiviral medications that prevent hepatitis C virus (HCV) from multiplying in the body.

Etymology

The name "Ledipasvir" is derived from the chemical name L-methyl-edine-parazine-sulfonamide-virus inhibitor. "Sofosbuvir" is derived from the chemical name Sodium fosphate butyrate virus inhibitor.

Usage

Ledipasvir/Sofosbuvir is used to treat chronic hepatitis C, a viral infection of the liver. It is used in adults and children aged 12 years and older, or weighing at least 77 pounds (35 kilograms).

Related Terms

  • Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
  • Antiviral: Medications used specifically for treating viral infections.
  • Sofosbuvir: An antiviral medication that prevents hepatitis C virus (HCV) from multiplying in your body.
  • Ledipasvir: An antiviral medication that prevents hepatitis C virus (HCV) from multiplying in your body.

Side Effects

Common side effects of Ledipasvir/Sofosbuvir include tiredness, headache, and difficulty sleeping. Serious side effects may include a slow heart rate and a reactivation of hepatitis B.

Precautions

Before taking Ledipasvir/Sofosbuvir, tell your doctor or pharmacist if you are allergic to either drug; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski